EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors

Noura Aldous, Ahmed K Elsayed, Bushra Memon, Sadaf Ijaz, Sikander Hayat, Essam M Abdelalim

Diabetologia · 2024

DOI: 10.1007/s00125-024-06232-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2024. Verfasst von Noura Aldous und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Education City, Doha, Qatar. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Regulatory Factor X Transcription Factors, Homeodomain Proteins, Cell Differentiation. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Qatar Biomedical Research Institute, Hamad Bin Khalifa University, Qatar Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis Homozygous mutations in RFX6 lead to neonatal diabetes accompanied by a hypoplastic pancreas, whereas heterozygous mutations cause MODY. Recent studies have also shown RFX6 variants to be linked with type 2 diabetes. Despite RFX6 ’s known function in islet development, its specific role in diabetes pathogenesis remains unclear. Here, we aimed to understand the mechanisms underlying the impairment of pancreatic islet development and subsequent hypoplasia due to loss-of-function mutations in RFX6 .

Methods

We examined regulatory factor X6 (RFX6) expression during human embryonic stem cell (hESC) differentiation into pancreatic islets and re-analysed a single-cell RNA-seq dataset to identify RFX6-specific cell populations during islet development. Furthermore, induced pluripotent stem cell (iPSC) lines lacking RFX6 were generated using CRISPR/Cas9. Various approaches were then employed to explore the consequences of RFX6 loss across different developmental stages. Subsequently, we evaluated transcriptional changes resulting from RFX6 loss through RNA-seq of pancreatic progenitors (PPs) and endocrine progenitors (EPs).

Results

RFX6 expression was detected in PDX1 + cells in the hESC-derived posterior foregut (PF). However, in the PPs, RFX6 did not co-localise with pancreatic and duodenal homeobox 1 (PDX1) or NK homeobox 1 (NKX6.1) but instead co-localised with neurogenin 3, NK2 homeobox 2 and islet hormones in the EPs and islets. Single-cell analysis revealed high RFX6 expression levels in endocrine clusters across various hESC-derived pancreatic differentiation stages. Upon differentiating iPSCs lacking RFX6 into pancreatic islets, a significant decrease in PDX1 expression at the PF stage was observed, although this did not affect PPs co-expressing PDX1 and NKX6.1. RNA-seq analysis showed the downregulation of essential genes involved in pancreatic endocrine differentiation, insulin secretion and ion transport due to RFX6 deficiency. Furthermore, RFX6 deficiency resulted in the formation of smaller islet organoids due to increased cellular apoptosis, linked to reduced catalase expression, implying a protective role for RFX6. Overexpression of RFX6 reversed defective phenotypes in RFX6 -knockout PPs, EPs and islets. Conclusions/interpretation These findings suggest that pancreatic hypoplasia and reduced islet cell formation associated with RFX6 mutations are not due to alterations in PDX1 + /NKX6.1 + PPs but instead result from cellular apoptosis and downregulation of pancreatic endocrine genes. Data availability RNA-seq datasets have been deposited in the Zenodo repository with accession link (DOI: https://doi.org/10.5281/zenodo.10656891 ). Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsRegulatory Factor X Transcription FactorsHomeodomain ProteinsCell DifferentiationOrganoidsIslets of LangerhansTrans-ActivatorsHumansBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

DiabetesEndocrine specificationIslet organoidsPancreatic hypoplasiaPancreatic progenitorsTranscription factors

Substanzen

Regulatory Factor X Transcription FactorsHomeodomain ProteinsTrans-ActivatorsBasic Helix-Loop-Helix ProteinsRfx6 protein, humanpancreatic and duodenal homeobox 1 proteinNKX6-1 protein, human

Autor:innen und Institutionen

  • College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Education City, Doha, Qatar.
  • Laboratory of Pluripotent Stem Cell Disease Modeling, Translational Medicine Department, Research Branch, Sidra Medicine, Doha, Qatar.
  • Diabetes Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
  • Stem Cell Core, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Doha, Qatar.
  • Department of Medicine 2 (Nephrology, Rheumatology, Clinical Immunology and Hypertension), RWTH Aachen University, Medical Faculty, Aachen, Germany.
  • College of Health and Life Sciences, Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), Education City, Doha, Qatar. emohamed3@sidra.org.

Förderung

  • Qatar Biomedical Research Institute, Hamad Bin Khalifa University
  • Qatar Foundation

Zitieren

APA

Aldous, N., Elsayed, A. K., Memon, B., Ijaz, S., Hayat, S., & Abdelalim, E. M. (2024). Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors. Diabetologia. https://doi.org/10.1007/s00125-024-06232-2

Vancouver

Aldous N, Elsayed AK, Memon B, Ijaz S, Hayat S, Abdelalim EM. Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors. Diabetologia. 2024. doi:10.1007/s00125-024-06232-2

BibTeX
@article{Aldous2024,
  author = {Aldous, Noura and Elsayed, Ahmed K and Memon, Bushra and Ijaz, Sadaf and Hayat, Sikander and Abdelalim, Essam M},
  title = {Deletion of RFX6 impairs iPSC-derived islet organoid development and survival, with no impact on PDX1+/NKX6.1+ progenitors},
  journal = {Diabetologia},
  year = {2024},
  doi = {10.1007/s00125-024-06232-2}
}
Kostenlos starten →